Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients

Thrombosis research

Volumn 134, Issue 3, 2014, Pages 639-642

  Nadir, Y ^a   Sarig, G ^a   Axelman, E ^a   Meir, A ^a   Wollner, M ^a   Shafat, I ^a   Hoffman, R ^a   Brenner, B ^a   Vlodavsky, I ^a   Haim, N ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Coagulation; Heparanase; Lung cancer; Prognosis

Indexed keywords

BETA GLUCURONIDASE; HEPARANASE; TUMOR MARKER;

AGED; BLOOD; BLOOD CLOTTING; CASE CONTROL STUDY; COMPLICATION; ENZYMOLOGY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; NON SMALL CELL LUNG CANCER; PROGNOSIS; RISK FACTOR; THROMBOSIS; TIME FACTOR; UPREGULATION;

AGED; BIOMARKERS, TUMOR; BLOOD COAGULATION; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GLUCURONIDASE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; THROMBOSIS; TIME FACTORS; UP-REGULATION;

EID: 84939998578     PISSN: None     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.07.006     Document Type: Article

References (0)